[ Price : $8.95]
OMB approves seven information collections that include humanitarian-use devices, Right-to-Try Act reporting, and positron emissio...[ Price : $8.95]
Three drug companies comment on an FDA draft guidance on immune-mediated adverse reactions in cancer drug trials.[ Price : $8.95]
Federal Register notice: FDA sends to OMB an information collection extension entitled Conflict-of-Interest Information for Partic...[ Price : $8.95]
A new Government Accountability Office report offers recommendations to shield FDA and other HHS agencies from political interfere...[ Price : $8.95]
Federal Register notice: FDA announces that OMB has approved a new information collection entitled Targeted Mechanism of Action Pr...[ Price : $8.95]
Federal Register notice: FDA issues an order debarring David J. Kempema for five years from importing or offering for import any d...[ Price : $8.95]
Pharmaceutical Research and Manufacturers of America calls on FDA to harmonize drug direct manufacturing and point-of-care manufac...[ Price : $8.95]
AdvaMed says it strongly supports FDA efforts to update a guidance on the breakthrough devices program.